18 results
424B5
DMAC
DiaMedica Therapeutics Inc.
11 Feb 20
Prospectus supplement for primary offering
5:31pm
qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel, effectively manage a geographically
8-K
EX-99.2
DMAC
DiaMedica Therapeutics Inc.
11 Feb 20
Updated Financial Information
7:05am
individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel, effectively manage a geographically dispersed
424B5
DMAC
DiaMedica Therapeutics Inc.
11 Feb 20
Prospectus supplement for primary offering
7:02am
and incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel, effectively manage
10-K
0uuk rq2k2406ntukw
19 Mar 19
Annual report
4:58pm
424B4
0j0153f
10 Dec 18
Prospectus supplement with pricing info
4:50pm
S-1/A
5ekf873u6h arsz
19 Nov 18
IPO registration (amended)
5:01pm
S-1
282av9qvfs hi
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.14
u6e cyeb8is
9 Nov 18
IPO registration
4:21pm
DRS
12u1 z9rad
1 Nov 18
Draft registration statement
12:00am
DRS
EX-10.14
cjaz2uw31yztjr
1 Nov 18
Draft registration statement
12:00am
DRS/A
3hnppmx4lpefwyrqj
19 Oct 18
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
4eldabe
19 Oct 18
Draft registration statement (amended)
12:00am
20FR12B/A
jfxrw 8mxm
11 Mar 14
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
rpyvgqtolnyaway4
30 Jan 14
Initial registration of securities (foreign private issuers)
12:00am
- Prev
- 1
- Next